1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Geriatric Medicines Revenue
• 1.4 Market by Type
  • 1.4.1 Global Geriatric Medicines Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Analgesics
  • 1.4.3 Antihypertensives
  • 1.4.4 Statins
  • 1.4.5 Antidiabetics
  • 1.4.6 Proton Pump Inhibitor
  • 1.4.7 Anticoagulant
  • 1.4.8 Antipsychotics
  • 1.4.9 Antidepressants
• 1.5 Market by Application
  • 1.5.1 Global Geriatric Medicines Market Share by Application: 2020 VS 2026
  • 1.5.2 Cardiovascular diseases
  • 1.5.3 Arthritis
  • 1.5.4 Neurological Disorders
  • 1.5.5 Cancer
  • 1.5.6 Osteoporosis
  • 1.5.7 Respiratory
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Geriatric Medicines Market Perspective (2015-2026)
• 2.2 Global Geriatric Medicines Growth Trends by Regions
  • 2.2.1 Geriatric Medicines Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Geriatric Medicines Historic Market Share by Regions (2015-2020)
  • 2.2.3 Geriatric Medicines Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Geriatric Medicines Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Geriatric Medicines Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Geriatric Medicines Players by Market Size
  • 3.1.1 Global Top Geriatric Medicines Players by Revenue (2015-2020)
  • 3.1.2 Global Geriatric Medicines Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Geriatric Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Geriatric Medicines Market Concentration Ratio
  • 3.2.1 Global Geriatric Medicines Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Geriatric Medicines Revenue in 2019
• 3.3 Geriatric Medicines Key Players Head office and Area Served
• 3.4 Key Players Geriatric Medicines Product Solution and Service
• 3.5 Date of Enter into Geriatric Medicines Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Geriatric Medicines Historic Market Size by Type (2015-2020)
• 4.2 Global Geriatric Medicines Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Geriatric Medicines Market Size by Application (2015-2020)
• 5.2 Global Geriatric Medicines Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Geriatric Medicines Market Size (2015-2020)
• 6.2 Geriatric Medicines Key Players in North America (2019-2020)
• 6.3 North America Geriatric Medicines Market Size by Type (2015-2020)
• 6.4 North America Geriatric Medicines Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Geriatric Medicines Market Size (2015-2020)
• 7.2 Geriatric Medicines Key Players in Europe (2019-2020)
• 7.3 Europe Geriatric Medicines Market Size by Type (2015-2020)
• 7.4 Europe Geriatric Medicines Market Size by Application (2015-2020)

8 China

• 8.1 China Geriatric Medicines Market Size (2015-2020)
• 8.2 Geriatric Medicines Key Players in China (2019-2020)
• 8.3 China Geriatric Medicines Market Size by Type (2015-2020)
• 8.4 China Geriatric Medicines Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Geriatric Medicines Market Size (2015-2020)
• 9.2 Geriatric Medicines Key Players in Japan (2019-2020)
• 9.3 Japan Geriatric Medicines Market Size by Type (2015-2020)
• 9.4 Japan Geriatric Medicines Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Geriatric Medicines Market Size (2015-2020)
• 10.2 Geriatric Medicines Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Geriatric Medicines Market Size by Type (2015-2020)
• 10.4 Southeast Asia Geriatric Medicines Market Size by Application (2015-2020)

11 India

• 11.1 India Geriatric Medicines Market Size (2015-2020)
• 11.2 Geriatric Medicines Key Players in India (2019-2020)
• 11.3 India Geriatric Medicines Market Size by Type (2015-2020)
• 11.4 India Geriatric Medicines Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Geriatric Medicines Market Size (2015-2020)
• 12.2 Geriatric Medicines Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Geriatric Medicines Market Size by Type (2015-2020)
• 12.4 Central & South America Geriatric Medicines Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Eli Lilly and Company
  • 13.1.1 Eli Lilly and Company Company Details
  • 13.1.2 Eli Lilly and Company Business Overview
  • 13.1.3 Eli Lilly and Company Geriatric Medicines Introduction
  • 13.1.4 Eli Lilly and Company Revenue in Geriatric Medicines Business (2015-2020))
  • 13.1.5 Eli Lilly and Company Recent Development
• 13.2 AstraZeneca
  • 13.2.1 AstraZeneca Company Details
  • 13.2.2 AstraZeneca Business Overview
  • 13.2.3 AstraZeneca Geriatric Medicines Introduction
  • 13.2.4 AstraZeneca Revenue in Geriatric Medicines Business (2015-2020)
  • 13.2.5 AstraZeneca Recent Development
• 13.3 Boehringer Ingelheim
  • 13.3.1 Boehringer Ingelheim Company Details
  • 13.3.2 Boehringer Ingelheim Business Overview
  • 13.3.3 Boehringer Ingelheim Geriatric Medicines Introduction
  • 13.3.4 Boehringer Ingelheim Revenue in Geriatric Medicines Business (2015-2020)
  • 13.3.5 Boehringer Ingelheim Recent Development
• 13.4 Abbott Laboratories
  • 13.4.1 Abbott Laboratories Company Details
  • 13.4.2 Abbott Laboratories Business Overview
  • 13.4.3 Abbott Laboratories Geriatric Medicines Introduction
  • 13.4.4 Abbott Laboratories Revenue in Geriatric Medicines Business (2015-2020)
  • 13.4.5 Abbott Laboratories Recent Development
• 13.5 Sanofi
  • 13.5.1 Sanofi Company Details
  • 13.5.2 Sanofi Business Overview
  • 13.5.3 Sanofi Geriatric Medicines Introduction
  • 13.5.4 Sanofi Revenue in Geriatric Medicines Business (2015-2020)
  • 13.5.5 Sanofi Recent Development
• 13.6 Bristol-Myers Squibb
  • 13.6.1 Bristol-Myers Squibb Company Details
  • 13.6.2 Bristol-Myers Squibb Business Overview
  • 13.6.3 Bristol-Myers Squibb Geriatric Medicines Introduction
  • 13.6.4 Bristol-Myers Squibb Revenue in Geriatric Medicines Business (2015-2020)
  • 13.6.5 Bristol-Myers Squibb Recent Development
• 13.7 Merck
  • 13.7.1 Merck Company Details
  • 13.7.2 Merck Business Overview
  • 13.7.3 Merck Geriatric Medicines Introduction
  • 13.7.4 Merck Revenue in Geriatric Medicines Business (2015-2020)
  • 13.7.5 Merck Recent Development
• 13.8 Novartis
  • 13.8.1 Novartis Company Details
  • 13.8.2 Novartis Business Overview
  • 13.8.3 Novartis Geriatric Medicines Introduction
  • 13.8.4 Novartis Revenue in Geriatric Medicines Business (2015-2020)
  • 13.8.5 Novartis Recent Development
• 13.9 Pfizer
  • 13.9.1 Pfizer Company Details
  • 13.9.2 Pfizer Business Overview
  • 13.9.3 Pfizer Geriatric Medicines Introduction
  • 13.9.4 Pfizer Revenue in Geriatric Medicines Business (2015-2020)
  • 13.9.5 Pfizer Recent Development
• 13.10 GSK
  • 13.10.1 GSK Company Details
  • 13.10.2 GSK Business Overview
  • 13.10.3 GSK Geriatric Medicines Introduction
  • 13.10.4 GSK Revenue in Geriatric Medicines Business (2015-2020)
  • 13.10.5 GSK Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer

Geriatric Medicines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Geriatric Medicines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Eli Lilly and Company
AstraZeneca
Boehringer Ingelheim
Abbott Laboratories
Sanofi
Bristol-Myers Squibb
Merck
Novartis
Pfizer
GSK

Market segment by Type, the product can be split into
Analgesics
Antihypertensives
Statins
Antidiabetics
Proton Pump Inhibitor
Anticoagulant
Antipsychotics
Antidepressants
Market segment by Application, split into
Cardiovascular diseases
Arthritis
Neurological Disorders
Cancer
Osteoporosis
Respiratory

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America